Curanex Pharmaceuticals, Inc. (CURX)
4.77
-0.22
(-4.41%)
USD |
NASDAQ |
Oct 07, 16:00
4.76
-0.01
(-0.21%)
Pre-Market: 20:00
Curanex Pharmaceuticals Debt to Equity Ratio : 0.0577 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0577 |
| March 31, 2026 | 0.0385 |
| December 31, 2025 | 0.0309 |
| September 30, 2025 | 0.0043 |
| June 30, 2025 | 1.560 |
| March 31, 2025 | 0.7961 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | |
| December 31, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Resonate Blends, Inc. | -1.103 |
| Kaya Holdings, Inc. | -- |
| Endexx Corp. | -- |
| Earth Science Tech, Inc. | 0.0481 |
| Eco-Growth Strategies, Inc. | -0.7664 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.074M |
| Total Liabilities (Quarterly) | 0.2863M |
| Shareholders Equity (Quarterly) | 4.788M |
| Current Ratio | 45.95 |
| Net Debt Paydown Yield | 0.04% |